Clarivate (NYSE:CLVT) Stock Price Up 7% – Here’s Why

Clarivate PLC (NYSE:CLVT) shot up 7% on Thursday . The stock traded as high as $2.41 and last traded at $2.3750. Approximately 1,363,752 shares traded hands during trading, a decline of 80% from the average session volume of 6,657,492 shares. The stock had previously closed at $2.22.

Analysts Set New Price Targets

CLVT has been the topic of a number of analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Clarivate in a research report on Wednesday, June 24th. Wall Street Zen raised Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Five analysts have rated the stock with a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Reduce” and a consensus target price of $3.22.

Clarivate Stock Performance

The company has a debt-to-equity ratio of 0.89, a current ratio of 0.84 and a quick ratio of 0.84. The company has a market capitalization of $1.65 billion, a price-to-earnings ratio of -12.26 and a beta of 1.38. The stock has a 50 day simple moving average of $2.41 and a two-hundred day simple moving average of $2.58.

Clarivate (NYSE:CLVT) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.04. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The company had revenue of $585.50 million during the quarter, compared to the consensus estimate of $569.50 million. During the same period in the previous year, the business earned $0.14 EPS. Clarivate’s revenue for the quarter was down 1.4% on a year-over-year basis. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. As a group, analysts anticipate that Clarivate PLC will post 0.65 earnings per share for the current year.

Hedge Funds Weigh In On Clarivate

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Personal CFO Solutions LLC purchased a new position in Clarivate in the first quarter valued at approximately $30,000. FreeGulliver LLC purchased a new stake in shares of Clarivate during the 1st quarter worth approximately $30,000. Principal Financial Group Inc. purchased a new stake in shares of Clarivate during the 1st quarter worth approximately $32,000. M&T Bank Corp acquired a new position in shares of Clarivate in the 4th quarter valued at $34,000. Finally, Parallel Advisors LLC boosted its holdings in shares of Clarivate by 94.2% in the 1st quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock valued at $35,000 after buying an additional 6,687 shares in the last quarter. 85.72% of the stock is owned by institutional investors and hedge funds.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.